Karyopharm Therapeutics Inc.’s Post

🚀 New Blog Series: Complexity Spectrum in Clinical Trials. We’re excited to kick off a three-part series with our latest blog post, exploring the 'Complexity Spectrum' in clinical trials. Part One dives into a low-complexity prostate cancer trial, highlighting how configurable and flexible approaches are tailored to optimize trial execution. Stay tuned as we continue this series, showcasing strategies for tackling medium and high-complexity trials, ultimately driving the development of more effective therapies 𝗥𝗲𝗮𝗱 𝗣𝗮𝗿𝘁 𝗢𝗻𝗲 𝗵𝗲𝗿𝗲: https://bit.ly/4csHYP1 #ClinicalTrials #HealthcareInnovation #PrecisionMedicine #ProstateCancer #Pharma #Biotech #Oncology #4GClinical

⛵️ The Oncology Race in Biotech: Voyage to First Approval ⛵️ Excited to share a fun new infographic! It highlights biotechs nearing their first oncology approval, showcasing their clinical programs and relative timelines. #Oncology #Biotech #ClinicalTrials #oraclelifesciences #cancermpact

🔍 Get a clear view of the regulatory landscape and make data-driven decisions. Visit our site for a free trial and demo to learn more → https://lnkd.in/dqzJEea4 #oncology #biotech #biotechnology #regulatoryaffairs #pharma #drugdevelopment #oncologytrials #oncologyresearch #cancer #oncology #regulatoryintelligence #regulatoryprecedent

📆 1 week to go! Come and see us at the Regulatory Affairs Professionals Society (RAPS) Regulatory Intelligence Conference in Baltimore. We're sharing RxTROSPECT trial access to those attending to celebrate the newly launched RAPS Conference Series. We hope to see you there! #oncology #biotech #biotechnology #regulatoryaffairs #pharma #drugdevelopment #oncologytrials #oncologyresearch #cancer #oncology #regulatoryintelligence #regulatoryprecedent

Developing a treatment for a rare cancer is challenging, but launching successfully to get treatment to patients at scale brings a new set of challenges. Read this case study to learn how our client exceeded revenue goals by 25%. https://lnkd.in/eT2PpbBP #AskHerspiegel #rarediseaseday2024 #pharma #gotomarketstrategy #launch #rarecancer #biotech #oncology

BREAKING: Just hours before America's biggest cancer conference kicks off, a small biotech called Summit Therapeutics, Inc. made waves with new late-stage results. Summit's cancer drug beat Merck's flagship immunotherapy Keytruda in a Phase 3 lung cancer study conducted in China. That led to a multibillion-dollar stock move, with Summit gaining over $5 billion in market value on Thursday, while Merck's shares dropped just over 1%. It will also re-open contentious questions about the willingness of FDA regulators and US oncologists to rely on China-based clinical results. The success also boosts the chances of a rare repeat success in biotech for CEO Bob Duggan, who previously ran Pharmacyclics, an AbbVie Company, before selling it in 2015 for $21 billion and becoming a billionaire. My latest for Endpoints News:

🎤 Thank you Regulatory Affairs Professionals Society (RAPS) for an incredible 3 days at the very first Regulatory Intelligence Conference in Baltimore this month. Fantastic speakers throughout and a very insightful workshop, focusing on regulatory precedent, to kickoff the event. We were honored to sponsor the event and look forward to seeing everybody again next year! #oncology #biotech #biotechnology #regulatoryaffairs #pharma #drugdevelopment #oncologytrials #oncologyresearch #cancer #oncology #regulatoryintelligence #regulatoryprecedent

March Market Update: Bi/Multi-Specifics Therapeutics in Oncology Sign up for Free market alerts: https://lnkd.in/dz6hcDd3 #bispecifics #multispecifics #cancer #oncology #cancerresearch #drugdiscovery #drugdevelopment #1stoncology #biotech #pharma #immunooncology #clinicaltrials

November Market Update: Bi/Multi-Specifics Therapeutics in Oncology Sign up for Free market alerts: https://lnkd.in/dz6hcDd3 #bispecifics #multispecifics #cancer #oncology #cancerresearch #drugdiscovery #drugdevelopment #1stoncology #biotech #pharma #immunooncology #clinicaltrials

Discover the leading companies driving innovations in bispecific antibodies with curated analytics by LARVOL CLIN. 🧬 Stay informed and ahead in the dynamic field of antibody therapeutics. Explore more here: https://bit.ly/4bFSDpD #BispecificAntibodies #LARVOLCLIN #BiotechLeaders #CancerData #Oncology